摘要
背景:认知训练是一种基于一系列反映特定认知功能的任务的非药理学干预。CT旨在提高认知患者的认知能力。虽然目前还没有明确的结论表明它在阿尔茨海默病(AD)中的作用。 目的:评价一种旨在提高AD患者认知能力的CT程序的有效性。 方法:采用随机、对照、单盲、纵向试验的方法,对轻度至中度AD患者进行无治疗对照试验.。治疗组每周接受CT两次,共6次。HS,而对照组没有。CT包括从纸和铅笔到口头学习练习的任务。参与者的认知水平在基线、干预后和6个月时进行评估。后来通过一组完整的神经心理学测试。采用重复测量方差分析时间对观察指标的影响,并比较治疗组和未治疗组的疗效。NTS随着时间的推移,人口数据被视为协变量。 结果:140例患者中,治疗组45例,对照组85例。CT治疗后即刻认知功能明显改善。六摩后来,一些测试分数与基线时相比保持稳定。对照组在每一时间点上的表现都明显低于治疗组,显示出一个进程。随着时间的推移,认知能力下降。 结论:CT可改善AD患者的认知功能,并可暂时延缓认知功能下降。
关键词: 阿尔茨海默病,认知训练,认知刺激,非药物干预,神经心理学评估,随机对照试验(RCT)。
Current Alzheimer Research
Title:Cognitive Training in Patients with Alzheimer's Disease: Findings of a 12-month Randomized Controlled Trial
Volume: 15 Issue: 5
关键词: 阿尔茨海默病,认知训练,认知刺激,非药物干预,神经心理学评估,随机对照试验(RCT)。
摘要: Background: Cognitive training (CT) is a non-pharmacological intervention based on a set of tasks that reflect specific cognitive functions. CT is aimed at improving cognition in patients with cognitive impairment, though no definitive conclusions have yet been drawn on its efficacy in Alzheimer's disease (AD).
Objective: To assess the effectiveness of a CT program designed to improve cognition in AD patients.
Method: This is a randomized, controlled, single-blind, longitudinal trial with a no-treatment control condition in mild-to-moderate AD. Treated patients received in-group CT twice a week for six months, whereas controls did not. CT consisted of tasks ranging from paper-and-pencil to verbal-learning exercises. Participants' cognitive levels were assessed at baseline, post-intervention and 6 months later by means of a complete neuropsychological test battery. Repeated measures ANOVA was used to analyze the effect of time on the outcome measures, as well as to compare treated and untreated patients over time, with demographic data considered as covariates.
Results: Of the 140 patients enrolled, 45 in the treated group and 85 controls concluded the study. The CT significantly improved treated subjects' cognitive functions immediately after the CT. Six months later, some test scores remained stable when compared with those obtained at baseline. The control group performed significantly worse than the treated group at each time-point, displaying a progressive cognitive decline over time.
Conclusion: Our results suggest that CT may improve cognitive functions in patients with AD and may help to temporarily slow their cognitive decline.
Export Options
About this article
Cite this article as:
Cognitive Training in Patients with Alzheimer's Disease: Findings of a 12-month Randomized Controlled Trial, Current Alzheimer Research 2018; 15 (5) . https://dx.doi.org/10.2174/1567205014666171113105044
DOI https://dx.doi.org/10.2174/1567205014666171113105044 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Drug Treatment of Metabolic Syndrome
Current Clinical Pharmacology End-Stage Dementia Spark of Life: Reliability and Validity of the “GATOS” Questionnaire
Current Alzheimer Research The Role of Nitric Oxide on Endothelial Function
Current Vascular Pharmacology S-nitrosation/Denitrosation in Cardiovascular Pathologies: Facts and Concepts for the Rational Design of S-nitrosothiols
Current Pharmaceutical Design Neurochemistry Changes Associated with Mutations in Familial Parkinsons Disease
Current Medicinal Chemistry Substance Abuse and Movement Disorders: Complex Interactions and Comorbidities
Current Drug Abuse Reviews Platelets in Atherothrombosis - Diagnostic and Prognostic Value of Platelet Activation in Patients with Atherosclerotic Diseases
Current Vascular Pharmacology Membrane Interacting Peptides: A Review
Current Protein & Peptide Science A Comprehensive Analysis of Unique and Recurrent Copy Number Variations in Alzheimer’s Disease and its Related Disorders
Current Alzheimer Research Is the Deficiency of Vitamin B12 Related to Oxidative Stress and Neurotoxicity in Parkinsons Patients?
CNS & Neurological Disorders - Drug Targets Therapeutic Trials in Human Transmissible Spongiform Encephalopathies: Recent Advances and Problems to Address
Infectious Disorders - Drug Targets Didehydro-Cortistatin A Inhibits HIV-1 Tat Mediated Neuroinflammation and Prevents Potentiation of Cocaine Reward in Tat Transgenic Mice
Current HIV Research Aluminum Excytotoxicity and NeuroAutotoImmunity: The Role of the Brain Expression of CD32+ (FcγRIIa), ICAM-1+ and CD3ع in Aging
Current Aging Science Leon Thal and the Alzheimers Disease Cooperative Study
Current Alzheimer Research Current Strategies and Novel Drug Approaches for Alzheimer Disease
CNS & Neurological Disorders - Drug Targets Is Nitric Oxide Assuming a Janus-Face in The Central Nervous System?
Current Medicinal Chemistry Clinical Significance of Cytokines and Chemokines in Neuropsychiatric Systemic Lupus Erythematosus
Current Rheumatology Reviews Modulation of Ischemic Brain Injury and Neuroinflammation by Adenosine A2A Receptors
Current Pharmaceutical Design Thioridazine: The Good and the Bad
Recent Patents on Anti-Infective Drug Discovery Inhibition of GSK3 Dependent Tau Phosphorylation by Metals
Current Alzheimer Research